Xylem's (XYL) "Buy (B)" Rating Reaffirmed at Weiss Ratings

Key Points

• Xylem's stock has been reaffirmed with a "Buy (B)" rating by Weiss Ratings, reflecting positive sentiment among investment analysts.
• Several analysts have recently increased their price targets for Xylem, with Barclays setting a new target at $165.00 and Zacks upgrading the stock to a "strong-buy" rating.
• Xylem reported quarterly earnings of $1.26 EPS, beating estimates and indicating a year-over-year revenue growth of 6.1%.

Xylem (NYSE:XYL - Get Free Report)'s stock had its "buy (b)" rating reissued by investment analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

A number of other equities analysts have also recently commented on the company. TD Cowen boosted their price target on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. Zacks Research raised Xylem from a "hold" rating to a "strong-buy" rating in a report on Monday, September 22nd. Mizuho upped their target price on Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a report on Friday, September 12th. Barclays began coverage on Xylem in a report on Friday, September 19th. They issued an "overweight" rating and a $165.00 target price for the company. Finally, Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $152.33.

Xylem Stock Performance

XYL traded up $0.87 during trading on Wednesday, hitting $149.00. The stock had a trading volume of 305,362 shares, compared to its average volume of 1,422,259. The company has a 50 day moving average price of $142.63 and a 200-day moving average price of $129.90. The firm has a market cap of $36.27 billion, a price-to-earnings ratio of 38.70, a P/E/G ratio of 2.59 and a beta of 1.13. Xylem has a one year low of $100.47 and a one year high of $151.16. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts predict that Xylem will post 4.65 EPS for the current year.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at approximately $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.27% of the company's stock.

Institutional Trading of Xylem

Several institutional investors and hedge funds have recently modified their holdings of XYL. Valley National Advisers Inc. raised its stake in shares of Xylem by 84.9% in the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after purchasing an additional 101 shares during the last quarter. Maseco LLP purchased a new stake in shares of Xylem in the second quarter worth approximately $31,000. Center for Financial Planning Inc. raised its stake in shares of Xylem by 52.0% in the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after purchasing an additional 91 shares during the last quarter. ST Germain D J Co. Inc. raised its stake in shares of Xylem by 950.0% in the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock worth $33,000 after purchasing an additional 228 shares during the last quarter. Finally, Headlands Technologies LLC raised its stake in shares of Xylem by 90.6% in the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock worth $36,000 after purchasing an additional 145 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.